Research & Development Directorate (RDD) Committee

TERMS OF REFERENCE

Purpose of the RDD | Other Core Functions | Membership | Meeting Dates | Agendas and Minutes Circulation | Quorum

Purpose of RDD

  • To contribute to and assist in the implementation of the Trust’s R&D Strategy.
  • Support the development, implementation and maintenance of and act as the ratifying body for, a complete, integrated and fully referenced set of Policies and Standard Operating Procedures to cover every relevant aspect of the management and governance of research activity at the Trust
  • To monitor and report on research activity, finances and governance to the Clinical Governance Management Groups and other relevant committees and groups of the Trust.
  • Critically appraise the annual Strategic Business Plan and yearly Report charting achievements against the Plan in pursuance of the Trust’s R&D Strategy.

Other core functions:

  • Assess the scientific and strategic value of applications for research activities seeking financial support from the Trust including but not limited to:

  • Internal Funding Applications (Items of expenditure > £10,000 to be brought to RDDC)

  • Pump Priming Applications

  • Research Fellow Funds

  • Research Champion Consultant level appointments

  • Point of contact and decision making re NIHR and UKCRN networks

  • Identification and targeted dissemination of portfolio and non-portfolio research funding opportunities

  • Oversight of: R&D Institute including statistics, Tissue Bank, Intellectual Property including external consultancy, CTBI Building and its function

  • Support for Library & Knowledge Services, where appropriate

  • Leadership, in conjunction with the University, of the development of the Heart and Lung Research Institute.

Roles of Members

  • RDD committee members will have a pivotal role in the promotion of research within the Trust and its relationship to both R&D and wider Trust operational and strategic planning. 
  • RDD committee members who are representatives from clinical groups will act as the first point of contact and the main conduit for the communication and dissemination of R&D issues to their clinical and business units.

In addition  all Clinical Groups will be expected to have:

i     R&D as a standing item on their agenda

 

ii     A designated Research Officer from the RDD committee who will attend relevant meetings.

 

2    Clinical Group representatives will be expected to:

i     Undertake dual representation i.e. representation of all of their clinical group  constituents on the RDD and of the RDD on their clinical group

 

ii     Promote and champion R&D at their clinical/business unit meetings

 

iii    Conduct (or arrange the conduct of) clinical peer review of new projects

This Directorate model will enable new projects to be properly assessed alongside any service requirements that are needed for their introduction.

Any conflicts that arise will be dealt with by the RDD committee.

 

Membership

Core Members / Representatives: Clinical Director of R&D (Chair), Senior R&D Manager

Clinical Group/Business Unit Representatives: Cardiology, Pathology,Radiology, Research Campion, Secretarial Support, Statistician, Surgery, Theatres, Critical Care and Anaesthetics, Thoracic Medicine, Tissue Bank, Transplant, University of Cambridge.

Other Attendees:Education (inc. External),Finance,Library Services,Nursing and Professions Allied to Medicine,Pharmacy,R&D Admin & Finance Manager

Observers from within the R&D Department are welcome with prior discussion with the Senior R&D Manager or the Clinical Director.

Core members will observe an RDD meeting attendance policy. Attendance at 10 meetings per year is the expected minimum standard. Failure to attend 2 consecutive meetings (with failure to provide a deputy) will trigger a letter from the Chair.

                                          

The RDD Comprises

RDD
Dr Ian Smith (Chair) Clinical Director, R&D
Mr Yasir Abu-Omar Consultant Surgeon & R&D Representative for Surgery
Dr Bobby Agrawal Consultant Radiologist & R&D Representative for Radiology
Prof. Martin Bennett BHF Professor of Cardiovascular Sciences, University of Cambridge
  Library and Knowledge Services Manager
Dr Martin Goddard Clinical Lead for Tissue Bank
Dr Jules Hernandez-Sanchez Statistician

Dr Stephen Hoole 

Consultant Cardiologist & R&D Representative for Tissue Bank
Dr Vicky Hughes Senior R&D Manager
Sophie Jackson Research Manager
Dr Clive Lewis Lead for External Education
Prof Nick Morrell Professor of Cardiopulmonary Medicine, University of Cambridge
Dr Jas Parmar Consultant Physician & R&D Representative for Cardiothoracic Transplantation
Dr Doris Rassl Consultant Histopathologist & R&D Representative for Tissue Bank
Dr Robert Rintoul Consultant Respiratory Physician & R&D Representative for Thoracic Medicine
Jane Elliott Nursing Directorate
Dr Kiran Salaunkey Consultant Anaesthetist
Rosie Thornton Finance Manager
Dr Mark Toshner Consultant Respiratory Physician & 'Research Champion'
Dr Nick West Consultant Cardiologist

 

Quorom

The Directorate shall be deemed quorate if there is representation of:

Director of R&D (or deputy)
R&D Directorate representative
Four representatives from clinical groups/business units.

Dates of Meetings

Meetings are held every month, on the second Friday of the month, and will commence promptly at 8.00am.  Duration of the meetings will be up to two hours depending on the agenda.

Agenda, minutes and reporting

The RDD committee meeting agenda will be determined primarily by the Director of R&D and the Senior R&D Manager, and will be circulated together with briefing papers a minimum of three working days prior to the next meeting to enable sufficient time for Directorate Members to give them due consideration.  .

A detailed Action List summarising all actions will be produced and distributed to Directorate members within 5 working days of the meeting.  Minutes of Directorate meeting will be formally recorded and distributed to Directorate Members prior to the next meeting. 

Circulation of Minutes

Members of the Research & Development Directorate, Chief Executive, Medical Director and Research Officers.

Click here to return to top of the page